Welcome
Advances in breast cancer testing and treatment have greatly improved patient outcomes. Knowing a woman's HER-2 status is an essential component to understanding how to treat breast cancer and potentially extend survival. This web site will provide you with an overview of the HER-2 testing options currently available and why studies have consistently shown that the PathVysion HER-2 test, which employs FISH technology, can help overcome technical and interpretative limitations of other testing methods to accurately and reproducibly assess a woman's tumor for HER-2 status.1
1. Sauter G, et al. Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations. J Clin Oncol 27:1323-1333, 2009.
